I agree that this site is using cookies. You can find further informations here.
X
Wada, Fumito
54  results:
Search for persons X
?
1

Rational design of prodrug-type apoB-targeted siRNA for nuc..:

Hayashi, Junsuke ; Ochi, Yosuke ; Senpuku, Kota...
Bioorganic & Medicinal Chemistry.  104 (2024)  - p. 117693 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Prodrug‐Type Phosphotriester Oligonucleotides with Linear D..:

Sugimoto, Norihito ; Hayashi, Junsuke ; Funaki, Ryohei...
ChemBioChem.  24 (2023)  24 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
3

Highly Potent GalNAc-Conjugated Tiny LNA Anti-miRNA-122 Ant..:

Yamamoto, Tsuyoshi ; Mukai, Yahiro ; Wada, Fumito...
Pharmaceutics.  13 (2021)  6 - p. 817 , 2021
Link: https://doi.org/10.3390/..
 
?
4

Drug discovery and development scheme for liver-targeting b..:

Wada, Fumito ; Yamamoto, Tsuyoshi ; Kobayashi, Tadayuki...
Molecular Therapy - Nucleic Acids.  26 (2021)  - p. 957-969 , 2021
Link: https://doi.org/10.1016/..
 
?
5

Effect of modular conjugation strategy forN-acetylgalactosa..:

Yamamoto, Tsuyoshi ; Sawamura, Motoki ; Terada, Chisato...
Nucleosides, Nucleotides & Nucleic Acids.  39 (2019)  1-3 - p. 109-118 , 2019
Link: https://doi.org/10.1080/..
 
?
6

Preclinical Pharmacology and Safety Studies of GalNAc-conju..:

Wada, Fumito ; Yamamoto, Tsuyoshi ; Tachibana, Keisuke..
Atherosclerosis Supplements.  32 (2018)  - p. 143 , 2018
Link: https://doi.org/10.1016/..
 
?
7

Effective gene silencing activity of prodrug-type 2′-O-meth..:

Hayashi, Junsuke ; Nishigaki, Misa ; Ochi, Yosuke...
Bioorganic & Medicinal Chemistry Letters.  28 (2018)  12 - p. 2171-2174 , 2018
Link: https://doi.org/10.1016/..
 
?
8

Synthesis, duplex-forming ability, enzymatic stability, and..:

Osawa, Takashi ; Sawamura, Motoki ; Wada, Fumito...
Organic & Biomolecular Chemistry.  15 (2017)  18 - p. 3955-3963 , 2017
Link: https://doi.org/10.1039/..
 
?
9

Antisense Oligonucleotides Targeting Y-Box Binding Protein-..:

Setoguchi, Kiyoko ; Cui, Lin ; Hachisuka, Nobutaka...
Molecular Therapy - Nucleic Acids.  9 (2017)  - p. 170-181 , 2017
Link: https://doi.org/10.1016/..
 
?
10

Efficacy and safety of antisense drug targeting PCSK9 in no..:

Harada-Shiba, Mariko ; Wada, Fumito ; Kobayashi, Tadayuki.
Atherosclerosis.  263 (2017)  - p. e245 , 2017
Link: https://doi.org/10.1016/..
 
?
11

Effect of an N-substituent in sulfonamide-bridged nucleic a..:

Mitsuoka, Yasunori ; Aoyama, Hiroshi ; Kugimiya, Akira...
Organic & Biomolecular Chemistry.  14 (2016)  27 - p. 6531-6538 , 2016
Link: https://doi.org/10.1039/..
 
?
12

Evaluation of the effects of chemically different linkers o..:

Wada, Shunsuke ; Yasuhara, Hidenori ; Wada, Fumito...
Journal of Controlled Release.  226 (2016)  - p. 57-65 , 2016
Link: https://doi.org/10.1016/..
 
?
13

Triazole- and Tetrazole-Bridged Nucleic Acids: Synthesis, D..:

Mitsuoka, Yasunori ; Yamamoto, Tsuyoshi ; Kugimiya, Akira...
The Journal of Organic Chemistry.  82 (2016)  1 - p. 12-24 , 2016
Link: https://doi.org/10.1021/..
 
?
14

Serial incorporation of a monovalent GalNAc phosphoramidite..:

Yamamoto, Tsuyoshi ; Sawamura, Motoki ; Wada, Fumito..
Bioorganic & Medicinal Chemistry.  24 (2016)  1 - p. 26-32 , 2016
Link: https://doi.org/10.1016/..
 
?
15

Development of Antisense Drugs for Dyslipidemia:

Yamamoto, Tsuyoshi ; Wada, Fumito ; Harada-Shiba, Mariko
Journal of Atherosclerosis and Thrombosis.  23 (2016)  9 - p. 1011-1025 , 2016
Link: https://doi.org/10.5551/..
 
1-15